PIM
PFE icon

Penobscot Investment Management’s Pfizer PFE Stock Holding History

Penobscot Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
79,410
-2
-0% -$52 0.13% 127
2026
Q1 		$2.23M Sell
79,412
-837
-1% -$22.3K 0.17% 113
2025
Q4 		$2M Sell
80,249
-1,575
-2% -$39.7K 0.15% 126
2025
Q3 		$2.08M Sell
81,824
-4,402
-5% -$109K 0.16% 118
2025
Q2 		$2.09M Sell
86,226
-9,075
-10% -$212K 0.18% 107
2025
Q1 		$2.41M Buy
95,301
+2,527
+3% +$66.1K 0.23% 94
2024
Q4 		$2.46M Sell
92,774
-1,740
-2% -$47.2K 0.22% 93
2024
Q3 		$2.74M Buy
94,514
+2,890
+3% +$84.3K 0.25% 90
2024
Q2 		$2.56M Sell
91,624
-565
-0.6% -$15.6K 0.25% 82
2024
Q1 		$2.56M Sell
92,189
-10,780
-10% -$299K 0.27% 78
2023
Q4 		$2.96M Sell
102,969
-750
-0.7% -$22.7K 0.35% 66
2023
Q3 		$3.44M Buy
103,719
+12,597
+14% +$445K 0.47% 53
2023
Q2 		$3.34M Sell
91,122
-500
-0.5% -$19.5K 0.55% 47
2023
Q1 		$3.74M Sell
91,622
-1,865
-2% -$80.5K 0.65% 42
2022
Q4 		$4.79M Hold
93,487
– – 0.84% 35
2022
Q3 		$4.09M Hold
93,487
– – 0.76% 36
2022
Q2 		$4.9M Hold
93,487
– – 0.85% 36
2022
Q1 		$4.84M Buy
93,487
+112
+0.1% +$5.81K 0.71% 41
2021
Q4 		$5.51M Hold
93,375
– – 0.74% 41
2021
Q3 		$4.02M Buy
93,375
+300
+0.3% +$13.3K 0.6% 48
2021
Q2 		$3.65M Sell
93,075
-2,472
-3% -$96.1K 0.54% 52
2021
Q1 		$3.46M Sell
95,547
-5,210
-5% -$185K 0.55% 51
2020
Q4 		$3.71M Buy
100,757
+1,833
+2% +$67.2K 0.62% 48
2020
Q3 		$3.44M Sell
98,924
-1,318
-1% -$46.2K 0.65% 46
2020
Q2 		$3.11M Hold
100,242
– – 0.64% 48
2020
Q1 		$3.1M Sell
100,242
-1,907
-2% -$65K 0.73% 43
2019
Q4 		$3.8M Sell
102,149
-8,465
-8% -$302K 0.71% 45
2019
Q3 		$3.77M Sell
110,614
-10,224
-8% -$372K 0.75% 45
2019
Q2 		$4.97M Sell
120,838
-790
-0.6% -$31.4K 1.02% 34
2019
Q1 		$4.9M Buy
121,628
+17,802
+17% +$713K 1.04% 36
2018
Q4 		$4.3M Buy
103,826
+5,333
+5% +$221K 1.03% 34
2018
Q3 		$4.12M Sell
98,493
-185
-0.2% -$7.12K 0.89% 39
2018
Q2 		$3.4M Sell
98,678
-606
-0.6% -$20.7K 0.79% 48
2018
Q1 		$3.34M Buy
99,284
+6,003
+6% +$206K 0.8% 47
2017
Q4 		$3.21M Sell
93,281
-228
-0.2% -$7.77K 0.89% 43
2017
Q3 		$3.17M Hold
93,509
– – 0.95% 38
2017
Q2 		$2.98M Sell
93,509
-1,338
-1% -$42.2K 0.96% 36
2017
Q1 		$3.08M Sell
94,847
-422
-0.4% -$13.3K 1.03% 34
2016
Q4 		$2.94M Buy
95,269
+1,191
+1% +$36.4K 1.01% 35
2016
Q3 		$3.02M Buy
94,078
+1,493
+2% +$49.9K 1.06% 32
2016
Q2 		$3.09M Sell
92,585
-106
-0.1% -$3.38K 1.1% 29
2016
Q1 		$2.61M Sell
92,691
-27,720
-23% -$792K 0.98% 34
2015
Q4 		$3.69M Hold
120,411
– – 1.16% 25
2015
Q3 		$3.59M Sell
120,411
-2,463
-2% -$79K 1.2% 25
2015
Q2 		$3.91M Buy
122,874
+1,686
+1% +$54.9K 1.21% 22
2015
Q1 		$4M Sell
121,188
-7,892
-6% -$251K 1.27% 22
2014
Q4 		$3.81M Sell
129,080
-5,692
-4% -$163K 1.2% 23
2014
Q3 		$3.78M Buy
134,772
+1,552
+1% +$43.6K 1.26% 20
2014
Q2 		$3.75M Sell
133,220
-208
-0.2% -$5.93K 1.26% 22
2014
Q1 		$4.07M Sell
133,428
-3,264
-2% -$97.3K 1.44% 15
2013
Q4 		$3.97M Buy
136,692
+418
+0.3% +$12.2K 1.41% 17
2013
Q3 		$3.71M Buy
136,274
+3,733
+3% +$102K 1.46% 16
2013
Q2 		$3.52M Buy
+132,541
New +$3.66M 1.47% 15

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Penobscot Investment Management's PFE Position: Q2 2026 in Review

Penobscot Investment Management reduced its Pfizer (PFE) stake by 0% in Q2 2026, selling an estimated $52 and leaving 79,410 shares worth $1.91M. The position accounts for 0.13% of the portfolio, ranked #127.

Penobscot Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.51M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Penobscot Investment Management held 79,410 shares of Pfizer worth $1.91M as of Q2 2026.
  • Penobscot Investment Management sold 2 Pfizer shares in Q2 2026, an estimated $52.
  • Pfizer made up 0.13% of Penobscot Investment Management's portfolio in Q2 2026, its #127 holding.
  • Penobscot Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Pfizer position peaked at $5.51M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.